
Paxlovid doesn’t help young people
On August 24, the “New England Journal of Medicine” published a real-world data of Pfizer’s new crown oral drug Paxlovid (nirmatrelvir + ritonavir) against Omicron
On August 24, the “New England Journal of Medicine” published a real-world data of Pfizer’s new crown oral drug Paxlovid (nirmatrelvir + ritonavir) against Omicron